Privi Speciality Chemicals share news, announcements and annual reports
NSE: PRIVISCLBSE: 530117Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,296.30.
30 Oct: open ₹3,299.00, high ₹3,313.80, low ₹3,168.60
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹12,571 Cr505th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.98
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.61
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,12,97953.8% delivered
Privi Speciality Chemicals share news and announcements
536 announcements, routine notices left out, newest first. Page 10 of 11.
May 2017
12 May · Legal
Exchange has sought clarification from Fairchem Speciality Limited with respect to announcement dated 12-May-2017, regarding Outcome of Board Meeting held on May 11, 2017.". On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment;2. Brief profile (in case of appointment);3. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.12 May · Board meeting
11 May · Results
Apr 2017
Mar 2017
15 Mar · Board meeting
14 Mar · Board meeting
Feb 2017
1 Feb · Results
Jan 2017
25 Jan · Meeting
18 Jan · Court Convened Meeting Updates
16 Jan · Court Convened Meeting Updates
13 Jan · Name and Symbol Change
Members of the Exchange are hereby informed that the name of "Adi Finechem Limited" shall be changed to "Fairchem Speciality Limited" and the trading symbol of the Company be changed from "ADI" to "FAIRCHEM" w.e.f. January 19, 2017.
Dec 2016
26 Dec · Court Convened Meeting Updates
20 Dec · Board meeting
Oct 2016
24 Oct · Results
7 Oct · Name Change
Sep 2016
14 Sep · Regulation 44(3) of SEBI (LODR), Reg., 2015
12 Sep · Regulation 44(3) of SEBI (LODR), Reg., 2015
Aug 2016
13 Aug · Meeting
Jul 2016
14 Jul · Legal
Exchange has sought clarification from Adi Finechem Limited with respect to announcement dated July 13, 2016, regarding the Outcome of Board Meeting held on July 12, 2016.On basis of above the Company is required to clarify following:1. Name of the entity (ies) forming part of the amalgamation/merger, details in brief such as, size, turnover etc.;2. Whether the transaction would fall within related party transactions? If yes, whether the same is done at "arm's length";3. Area of business of the entity (ies);4. Rationale for amalgamation/ merger;The response of the Company is awaited.13 Jul · Business
Jun 2016
16 Jun · Board meeting
May 2016
Apr 2016
29 Apr · Board meeting